Unjha Formulations (Small Cap - Next Multibagger) Share Target 2025, 2026 To 2035
|
Unjha Formulations Limited |
|||
|
Price: ₹30.60 (-0.13%) | ||
| 52 Week Low: ₹16.08 52 Week High: ₹39.00 |
|||
| Market Capital: 13.67 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Unjha Formulations Share Price Target For 2025
- 1.1.1: Unjha Formulations Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Unjha Formulations Share Price Target For 2026
- 1.2.1: Unjha Formulations Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Unjha Formulations Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Unjha Formulations Financial Performance
- 3.0.1: Is Unjha Formulations A Good Buy For Long Term?
To predict the Unjha Formulations's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Unjha Formulations Share Price Target For 2025
The line chart displays the monthly closing prices of Unjha Formulations with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Unjha Formulations shares in 2025, see the table below.
Unjha Formulations Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 34.95 (+14.21%) | Price Action: Oct 2024 High |
| 2025 Target 2 | 34.49 (+12.71%) | Price Action: 15 Oct 2024 High |
| 2025 Target 1 | 33.99 (+11.07%) | Price Action: Dec 2024 High |
| Current Price | 30.60 | Unjha Formulations's share price as of 02 Jan 2025 |
| Stop Loss 1 | 29.05 (-5.07%) | Price Action: 12 Nov 2024 Low |
| Stop Loss 2 | 28.7 (-6.21%) | Price Action: 29 May 2024 High |
| Stop Loss 3 | 28.35 (-7.36%) | Price Action: 07 Oct 2024 High |
Short-Term Technical Outlook
Current Technical Position: Unjha Formulations is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹30.66 serves as the nearest technical reference point.
Historical Returns: 3-month: +1.8% | 6-month: +29.99% | 1-year: +64.52%
Unjha Formulations Share Price Target For 2026
The line chart displays the monthly closing prices of Unjha Formulations with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Unjha Formulations shares in 2026, see the table below.
Unjha Formulations Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 50.49 (+65%) | Price Action: Chart |
| 2026 Target 2 | 49.55 (+61.92%) | Price Action: Chart |
| 2026 Target 1 | 49.06 (+60.32%) | Fibonacci Extension Level 64.90% |
| Current Price | 30.60 | Unjha Formulations's share price as of 02 Jan 2025 |
| Stop Loss 1 | 26.37 (-13.83%) | Price Action: 02 Jul 2024 High |
| Stop Loss 2 | 26.01 (-15%) | Price Action: 01 Oct 2024 Low |
| Stop Loss 3 | 25.67 (-16.12%) | Price Action: 14 Jun 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Unjha Formulations is currently trading at 63.4% of its 52-week range (₹16.08 - ₹39).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +64.52% | 3-year: +191.43% | 5-year: +387.26%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Unjha Formulations Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹30.60 | ||
| 2025 | ₹45.10 | +47.38% | ₹45.78 |
| 2026 | ₹55.17 | +22.32% | ₹56.00 |
| 2027 | ₹63.64 | +15.35% | ₹64.59 |
| 2028 | ₹83.50 | +31.2% | ₹84.75 |
| 2029 | ₹89.47 | +7.14% | ₹90.81 |
| 2030 | ₹93.94 | +4.99% | ₹95.35 |
| 2031 | ₹124.33 | +32.35% | ₹126.19 |
| 2032 | ₹137.86 | +10.88% | ₹139.93 |
| 2033 | ₹142.35 | +3.25% | ₹144.49 |
| 2034 | ₹168.67 | +18.48% | ₹171.20 |
| 2035 | ₹196.04 | +16.22% | ₹198.98 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Unjha Formulations Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 13.67 Crore | Market valuation of Unjha Formulations's shares. |
| Revenue (TTM) | 13.15 Crore | Total revenue generated by Unjha Formulations over the past twelve months. |
| Net Income (TTM) | +28.25 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.94% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +20.23% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+16.41% | Change in revenue compared to the previous quarter. |
Is Unjha Formulations A Good Buy For Long Term?
Unjha Formulations, a small-cap stock with a market cap of 13.67 Crore, has shown impressive financial performance in the past. Its revenue growth of 16.41% in the last quarter and a profit margin of 20.24% indicate a healthy financial position. However, with limited information available, it is difficult to make a definitive assessment. Further analysis of the company's financials, industry outlook, and competitive landscape is recommended before making an investment decision.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
